MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma

Cancer Epidemiology

Volumn 33, Issue 2, 2009, Pages 142-146

  de Lima, Marina de Deus Moura ^a   Marques, Yonara Maria Freire Soares ^a   de Melo Alves Jr , Sérgio ^a   Freitas, Vanessa Morais ^a   Soares, Fernando Augusto ^a   de Araújo, Vera Cavalcanti ^b   dos Santos Pinto Jr , Décio ^a   Mantesso, Andrea ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

Adenoid cystic carcinoma; MDM2; P21WAF1; P53; pAKT

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MDM2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND TUMOR; WESTERN BLOTTING; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; SALIVARY GLAND; TUMOR CELL CULTURE;

BLOTTING, WESTERN; CARCINOMA, ADENOID CYSTIC; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MDM2; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68249158297     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.04.016     Document Type: Article

References (25)

1. Gohring U.J., Bersch A., Becker M., Neuhaus W., and Schondorf T. p21waf correlates with DNA replication but not with prognosis in invasive breast cancer. J Clin Pathol 4 (2001) 866-870
2. Lane D.P. P53 guardian of the genome. Nature 358 (1992) 15-16
3. Broll R., Stark A., Windhövel U., Best R., Strik M.W., Schimmelppening H., et al. Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas. Eur J Cancer 35 (1999) 1083-1088
4. Cohen Y.L., Haupt S., and Haupt Y. Mdm2 in growth signaling and cancer. Growth Factors 23 (2005) 183-192
5. Roth J., Dobbelstein M., Freedman D.A., Shenk T., and Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 17 (1998) 554-564
6. Strous G.J., and Schantl J.A. Beta-arrestin and Mdm2, unsuspected partners in signaling from the cell surface. Sci STKE 110 (2001) PE41
7. Araújo V.C., Martins M.T., Leite K.R.M., and Araújo N.S. Immunohistochemical Mdm2 expression in minor salivary gland tumours and its relationship to p53 status. Oral Oncol 36 (2000) 67-69
8. Mantesso A., Loducca S.V., Bendit I., Garicochea B., Nunes F.D., and Araújo V.C. Mdm2 mRNA expression in salivary gland tumour cell lines. J Oral Pathol Med 33 (2004) 96-101
9. Woods D.B., and Vousden K.H. Regulation of p53 function. Exp Cell Res 264 (2001) 56-66
10. Datta M.W., Macri E., Signoretti S., Renshaw A.A., and Loda M. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression. Mod Pathol 14 (2001) 437-442
11. Freitas V.M., and Jaegger R.G. The effect of laminin and its peptide SIKVAV on a human salivary gland adenoid cystic carcinoma cell line. Virchows Arch 441 (2002) 569-576
12. Lehman T.A., Modali R., Boukamp P., Stanek J., Bennet W.P., Welsh J.A., et al. P53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14 (1993) 833-839
13. Longhi A., Benassi M.S., Molendini L., Macchiagodena M., Picci P., and Bacci G. Osteosarcoma in blood relatives. Oncol Rep 8 (2001) 131-136
14. Amornphimalthan P., Sriuranpona V., Patel V., Benavides F., Conti J., Sauk J., et al. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 15 (2004) 4029-4037
15. Nemes J.A., Nemes Z., and Marton I.J. P21 WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 34 (2005) 274-279
16. Michael D., and Oren M. The p53 and MDM2 families in cancer. Curr Opin Genet Dev 12 (2002) 53-59
17. Vestey S.B., Sen C., Calder C.J., Perks C.M., Pignatelli M., and Winters Z.E. Activated Akt expression in breast cancer: correlation with p53 Hdm2 and patient outcome. Eur J Cancer 41 (2005) 1017-1025
18. Bueso-Ramos C.E., Deleon E., Mccown P., Stass S.A., and Albitar M. The human Mdm2 oncogene is overexpressed in leukemias. Blood 82 (1993) 2617-2623
19. Jia L., Esguerra R.L., Tang X., Yin H., Sakamoto K., Okada N., et al. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int 54 (2004) 217-223
20. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277 (2002) 21843-21850
21. Mayo L.D., and Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98 (2001) 11598-11603
22. Gottlieb T.M., Leal J.F., Seger R., Taya Y., and Oren M. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 21 (2002) 1299-1303
23. Dodd R.L., and Slevin N.J. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42 (2006) 759-769
24. Papadaki H., Finkelstein F.D., Kounelis S., Bakker A., Swalsky P.A., and Kapadia S.B. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Human Pathol 27 (1996) 567-572
25. Perez D.E.C., Alves F.A., Nishimoto I.N., Almeida O.P., and Kowalski L.P. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 42 (2006) 139-146